Page last updated: 2024-11-03

procaterol and Migraine Disorders

procaterol has been researched along with Migraine Disorders in 1 studies

Procaterol: A long-acting beta-2-adrenergic receptor agonist.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Thalamic involvement in migraine is attractive given the complex and widespread nature of the sensory disturbance."1.33Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? ( Goadsby, PJ; Shields, KG, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shields, KG1
Goadsby, PJ1

Other Studies

1 other study available for procaterol and Migraine Disorders

ArticleYear
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
    Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glut

2005